Exela Pharma Sciences
PrivateLast Round
Grant
Dec 22, 2022
Total Funding Raised
$87.83M
Company Overview
Exela Pharma Sciences is a pharmaceutical company that develops, manufactures, and markets proprietary and generic sterile injectable products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exela Pharma Sciences Comparables
Compare Exela Pharma Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SCA Pharma | 85% | |
| Sagent Pharmaceuticals | 84% | |
| Nephron Pharmaceuticals Corporation | 81% | |
Exela Pharma Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 22, 2022 | ||||
| Grant | May 5, 2022 | ||||
| Debt | Oct 1, 2021 | ||||
| Debt | Jul 24, 2013 | ||||
| Grant | Jan 3, 2013 | ||||
Series A | Jul 1, 2008 |
Exela Pharma Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Administration for Strategic Preparedness and Response | Grant |
| Presidio Partners | Series A |
| Trinity Capital | Debt |
| U.S. Department of Agriculture | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2025
Company requests new trial for patent infringement allegations.
- Dec 22, 2022
$2M grant from the Administration for Strategic Preparedness and Response.
Exela Pharma Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exela Pharma Sciences's valuation, stock price, and market status.